Loading…
Alumis Inc. is projected to rise to $37.35 by 2027, a +29% move from its current price of $28.95. ALMS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $27.89 | $28.95 | $30.06 | +0.01% |
| Aug 2 | $27.46 | $28.95 | $30.53 | +0.01% |
| Aug 3 | $27.13 | $28.96 | $30.90 | +0.02% |
| Aug 4 | $26.86 | $28.96 | $31.21 | +0.02% |
| Aug 5 | $26.63 | $28.96 | $31.49 | +0.03% |
| Aug 6 | $26.42 | $28.96 | $31.75 | +0.04% |
| Aug 7 | $26.23 | $28.96 | $31.98 | +0.04% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $26.23 | $28.96 | $31.98 | +0.04% |
| Week 2 | $25.18 | $28.97 | $33.34 | +0.08% |
| Week 3 | $24.41 | $28.99 | $34.42 | +0.13% |
| Week 4 | $23.78 | $29.00 | $35.36 | +0.17% |
| Week 5 | $23.24 | $29.01 | $36.22 | +0.21% |
| Week 6 | $22.76 | $29.02 | $37.01 | +0.25% |
| Week 7 | $22.33 | $29.03 | $37.75 | +0.29% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alumis Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of medicines for autoimmune disorders.
The company offers envudeucitinib, a TYK2 inhibitor for plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for the treatment of neuroinflammatory and neurodegenerative diseases.
It also develops lonigutamab, a monoclonal antibody targeting IGF-1R for the treatment of thyroid eye diseases; and interferon regulatory factor 5 (IRF5) to address immune dysfunction. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc.
in January 2022. Alumis Inc. was incorporated in 2021 and is headquartered in South San Francisco, California.
Alumis Inc. (ALMS) currently trades at $27.08 per share with a market cap of $3.45B and a rank of 1561.
The 30-day technical picture shows bullish sentiment with RSI14 at 50 and moving averages at SMA50 $24.49 and SMA200 $19.39, suggesting an underlying trend higher from recent levels. The stock’s near-term range spans from a low of $21.27 to a high of $34.48, and its annualized volatility stands at 70%.
Forecasts outline a multi-year bullish trajectory, beginning with a 2026 average price of $27.08 (min $8.31, max $36.61; ROI 0; sentiment NEUTRAL) and progressing toward higher averages in subsequent years, reaching a 2030 average of $53.99 and a 2050 average of $259.80, with sustained bullish sentiment and expanding ROI.
A major floor 34.4% below — a decisive break under it would weaken the trend.
The nearest floor, 20.4% below — buyers have tended to step in here.
The nearest ceiling, 4.7% above — a clean break opens room to run.
A major ceiling 19.8% above — clearing it would confirm fresh momentum.
Key ALMS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ALMS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $27.49 | Buy | $27.80 | Buy |
| MA 10 | $28.12 | Buy | $27.87 | Buy |
| MA 20 | $28.20 | Buy | $27.55 | Buy |
| MA 50 | $24.83 | Buy | $26.06 | Buy |
| MA 100 | $24.57 | Buy | $24.29 | Buy |
| MA 200 | $19.85 | Buy | $20.59 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.02 | Neutral |
| Stoch RSI (14) | 64.25 | Neutral |
| CCI (20) | 54.31 | Neutral |
| Williams %R (14) | -29.97 | Info |
| MACD (12,26,9) | -0.30 | Sell |
| ROC (12) | 6.12 | Buy |
| Bollinger %B (20,2) | 0.67 | Neutral |
| Stochastic %K (14) | 70.03 | Neutral |
| TRIX (15) | 0.59 | Buy |
| Awesome (5,34) | 0.78 | Buy |
| Ultimate (7,14,28) | 47.06 | Neutral |
| Momentum (10) | 1.72 | Buy |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 26.88 | Buy |
| ADX (14) | 17.14 | Neutral |
| ATR (14) | 0.99 | Info |
The 30-day picture is labeled bullish, with RSI 14 at 50 indicating room to move higher without being overbought.
SMA50 sits at $24.49, above the SMA200 of $19.39, pointing to positive momentum. Support is identified at $20.90 and resistance at $30.30, framing a constructive setup for a move higher.
The 30-day price range runs from $21.27 to $34.48, and the asset exhibits an annualized volatility of 70%, implying substantial price movement potential within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.31 | $28.95 | $39.57 | 0% | Neutral | |
| $28.77 | $37.35 | $51.83 | +29% | Bullish | |
| $35.13 | $47.48 | $69.21 | +64% | Bullish | |
| $40.99 | $57.30 | $86.73 | +98% | Bullish | |
| $43.50 | $62.66 | $97.87 | +116% | Bullish | |
| $45.66 | $67.61 | $108.52 | +134% | Bullish | |
| $43.95 | $66.79 | $109.83 | +131% | Bullish | |
| $46.96 | $73.13 | $122.91 | +153% | Bullish | |
| $61.72 | $98.38 | $168.68 | +240% | Bullish | |
| $68.42 | $111.55 | $194.84 | +285% | Bullish | |
| $82.66 | $149.63 | $282.17 | +417% | Bullish | |
| $156.11 | $341.77 | $719.26 | +10.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $8.31 | $28.95 | $33.81 | +0.00% |
| August 2026 | $23.80 | $28.15 | $34.24 | -2.77% |
| September 2026 | $24.32 | $29.11 | $36.05 | +3.41% |
| October 2026 | $25.61 | $30.94 | $38.87 | +6.30% |
| November 2026 | $25.44 | $30.97 | $39.36 | +0.10% |
| December 2026 | $25.14 | $30.82 | $39.57 | -0.49% |
Click any year to see its month-by-month ALMS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Alumis Inc.'s 2026 outlook centres on $28.95, within a $8.31 to $39.57 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, ALMS could reach as high as $51.83, with a base case around $37.35 and support toward $28.77 — roughly +29% from $28.95. Buyers look set to stay in control over this stretch.
Expect ALMS to range from $35.13 to $69.21 through 2028. The $47.48 average target implies a +64% move from current prices. That is up +27% on the projected 2027 average. Momentum favours further upside here.
The ALMS price prediction for 2029 points to an average of $57.30 (low $40.99, high $86.73) — a potential gain of +98% on today's $28.95. Buyers look set to stay in control over this stretch.
In 2030, ALMS is projected to trade between $43.50 and $97.87, averaging $62.66 — a potential gain of +116% from today's $28.95. That is up +9% on the projected 2029 average. Momentum favours further upside here.
Alumis Inc.'s 2031 outlook centres on $67.61, within a $45.66 to $108.52 range. That is up +8% on the projected 2030 average. That marks a +134% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, ALMS could reach as high as $109.83, with a base case around $66.79 and support toward $43.95 — roughly +131% from $28.95. Momentum favours further upside here.
Expect ALMS to range from $46.96 to $122.91 through 2033. The $73.13 average target implies a +153% move from current prices. That is up +9% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The ALMS price prediction for 2034 points to an average of $98.38 (low $61.72, high $168.68) — a potential gain of +240% on today's $28.95. Momentum favours further upside here.
In 2035, ALMS is projected to trade between $68.42 and $194.84, averaging $111.55 — a potential gain of +285% from today's $28.95. That is up +13% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Alumis Inc.'s 2040 outlook centres on $149.63, within a $82.66 to $282.17 range. That is up +34% on the projected 2035 average. That marks a +417% change versus current levels. Momentum favours further upside here.
By 2050, ALMS could reach as high as $719.26, with a base case around $341.77 and support toward $156.11 — roughly +10.8x from $28.95. Buyers look set to stay in control over this stretch.
Investing $1,000 in ALMS today (≈ 34.542314 ALMS) could be worth
$11,805.64
+$10,805.64 (+1081%) by 2050 · US Dollar
Based on the average projected ALMS price of $341.77 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ALMSwould be worth at today's price.
$1,000 invested in ALMS on Jul 30, 2025 (≈ 243.902445 ALMS) would be worth
$7,060.98
+$6,060.98 (+606.1%) today · 7.06× · US Dollar
Based on a ALMS entry price of $4.1 vs. today's $28.95.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $28.3 | $1,022.97 | +2.3% |
| 1 month ago | $28.14 | $1,028.78 | +2.9% |
| 3 months ago | $25.18 | $1,149.72 | +15.0% |
| 6 months ago | $24.51 | $1,181.15 | +18.1% |
| 1 year ago | $4.1 | $7,060.98 | +606.1% |
| All time (2.1y) ago | $13.3 | $2,176.69 | +117.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ALMS forecast.
Our base-case forecast reaches $58.00 around 2030.
Implied market cap at $58.00: $7.16B
The multi-year forecast shows a clear bullish arc, with the average price rising across the years and strong implied upside through 2050. By 2030 the average is projected at $53.99 with a max of $83.85 (ROI 99.4%), and the sentiment remains bullish.
In 2040 the forecast envisions an average of $115.03 and a max of $215.08 (ROI 324.8%), underscoring substantial appreciation if the path plays out. By 2050 the average price is forecast at $259.80 with a max of $541.28 (ROI 859.4%), accompanied by bullish sentiment across the longer horizon.
Across these years, the 2026 snapshot shows a min of $8.31, an average of $27.08, a max of $36.61, and a 0% ROI, marking a neutral near-term stance before the longer-term upside emerges. These figures illustrate an upward trajectory with meaningful upside potential, but they are estimates and not guarantees.
Tap a question to reveal the answer.
Avg price: $53.99; min $37.68; max $83.85; ROI 99.4%; sentiment BULLISH.
Forecast shows bullish sentiment from 2027 onward, with rising averages (e.g., 2027 $33.45, 2028 $41.30, 2029 $49.88, 2030 $53.99) and a long-term high of 2050 Avg $259.80 with ROI 859.4% (2026 is Neutral with Avg $27.08 and ROI 0%).
Yes. The max price is projected at $100.74 in 2033, with higher max values in later years (e.g., $133.93 in 2034 and $155.37 in 2035).
Current price is $27.08; market cap is $3.45B; rank 1561.
Min $121.06; avg $259.80; max $541.28; ROI 859.4%; sentiment BULLISH.
Alumis Inc. Community Discussion
0Share your Alumis Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.